Skip to main content

Table 2 CXL12 expression on single core level and patient level

From: CXCL12 expression is an adverse predictor for disease recurrence in patients with metastatic non-seminomatous testicular germ cell tumors

Single Cores

Semi-quantitative Score

 

negative

weak

moderate

strong

Seminoma (n = 422)

421 (99.8%)

0 (0.0%)

0 (0.0%)

1 (0.2%)

Embryonal Carcinoma (n = 172)

123 (70.7%)

0 (0.0%)

8 (4.6%)

43 (24.7%)

Teratoma (n = 29)

19 (59.3%)

0 (0.0%)

2 (6.3%)

11 (34.4%)

Yolk sack Tumor (n = 65)

5 (7.6%)

1 (1.5%)

11 (16.7%)

49 (74.2%)

Chorion Carcinoma (n = 7)

0 (0.0%)

0 (0.0%)

1 (14.3%)

6 (85.7%)

Patient Level

Dichotomized

 

Negative

Positive

Non Seminoma or mixed GCT (n = 99)

47 (47.5%)

52 (52.5%)

Pure Seminoma (n = 164)

164 (100%)

0 (0.0%)

Normal tissue (n = 40)

40 (100%)

0 (0.0%)

GCNIS (n = 9)

9 (100%)

0 (0.0%)

  1. Abbreviation: GCT germ cell tumor, GCNIS Germ cell neoplasia in situ